Cash Needed For Celiac Disease Drug Development

Link: https://www.lifescienceleader.com/doc/cash-needed-for-phase-celiac-drug-development-0001

James Sapirstein, CEO at Entero Therapeutics and a 40-year biopharmaceutical industry veteran, makes a compelling case for Big Pharma partners and investors to take a chance on a cheap and safe treatment that, if approved, would become the first drug indicated for patients with moderate to severe celiac disease.